Author

Marion Meyer

Lyon 1 Université

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:bacteria (other)· 1 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Amélie PereziD· 1 shared Angéline Gaucherot· 1 shared Aurelien L. CarlieriD· 1 shared Camille Jouines· 1 shared Carine FromentiD· 1 shared Caroline IsaaciD· 1 shared Christophe VanbelleiD· 1 shared Erin Hillairet· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Amélie PerezORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivPreprintJun 12, 2026

A fatal plant toxicosis described more than a century ago is caused by a bacterial endophyte

Sandra Moreau, Manon Canal, Erin Hillairet…·Aurelien L. Carlier

The study identifies pavettamine, a toxin causing gousiekte in livestock, as being synthesized by bacterial endophytes via a conserved gene cluster acquired through horizontal gene transfer.

DOI 10.64898/2026.06.12.731819

plant (other)bacteria (other)

𝕏 PostBluesky

Cancer BiologyBreast Cancer ResearchPeer-reviewedNov 13, 2025

Fibrillarin-mediated ribosomal RNA maturation is a novel therapeutic vulnerability in triple-negative breast cancer

Camille Jouines, Piero Lo Monaco, Angéline Gaucherot…·Frédéric Catez

This study identifies ribosome biogenesis as a therapeutic vulnerability in TNBC, showing that inhibiting rRNA maturation via Fibrillarin or RNA Pol I reduces tumor growth without significant cell death.

2 citations

humanbulk RNA-seq

𝕏 PostBluesky